Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Cisatracurium Besylate Patent Expiration

Cisatracurium Besylate is used for inducing muscle relaxation during surgical procedures. It was first introduced by Abbvie Inc in its drug Nimbex Preservative Free on Dec 15, 1995. Another drug containing Cisatracurium Besylate is Nimbex. 18 different companies have introduced drugs containing Cisatracurium Besylate.


Cisatracurium Besylate Patents

Given below is the list of patents protecting Cisatracurium Besylate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Nimbex US5453510 Neuromuscular blocking agents Sep 26, 2012

(Expired)

 Abbvie
Nimbex Preservative Free US5453510 Neuromuscular blocking agents Sep 26, 2012

(Expired)

 Abbvie



Cisatracurium Besylate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Cisatracurium Besylate Generic API Manufacturers

Several generic applications have been filed for Cisatracurium Besylate. The first generic version for Cisatracurium Besylate was by Sandoz Inc and was approved on Feb 3, 2012. And the latest generic version is by Hainan Poly Pharm Co Ltd and was approved on Aug 27, 2024.

Given below is the list of companies who have filed for Cisatracurium Besylate generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML

injectable Discontinued INJECTION N/A Jun 16, 2017
EQ 2MG BASE/ML

injectable Discontinued INJECTION N/A Jun 16, 2017





2. CAPLIN

Caplin Steriles Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Caplin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Jun 9, 2023
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Jun 9, 2023


Manufacturing Plant Locations
New

Caplin's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Caplin as present at those locations.

Country City Firm Name
United States
Creve Coeur Caplin, Dr David
India
Gummidipoondi Caplin Steriles Limited





3. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Cisatracurium Besylate. This eq 2mg base/ml version comes by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Oct 27, 2020


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Pashamylaram Eugia Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited





4. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Out of these eq 10mg base/ml version comes by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Feb 26, 2015
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Feb 26, 2015


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Skokie Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Grand Island Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
Wilson Fresenius Kabi USA, LLC





5. GLAND

Gland Pharma Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Gland.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML

injectable Prescription INJECTION AP May 24, 2022
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Dec 14, 2022


Manufacturing Plant Locations
New

Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.

Country City Firm Name
India
Hyderabad Gland Pharma Limited, Units I+II Pashamylaram Site
Parawada, Visakhapatnam Gland Pharma Limited
Aurangabad Gland Chemical Private Limited
Sriperumbudur Gland Chemical Private Limited
Hyderabad Gland Pharma Limited
Malur Gland Chemicals Pvt Ltd.
Visakhapatnam Gland Pharma Limited





6. HAINAN POLY

Hainan Poly Pharm Co Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Hainan Poly.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Discontinued INJECTION N/A Aug 27, 2024
EQ 10MG BASE/ML

injectable Discontinued INJECTION N/A Aug 27, 2024


Manufacturing Plant Locations
New

Hainan Poly's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hainan Poly as present at those locations.

Country City Firm Name
China
Haikou Hainan Poly Pharm. Co., Ltd.





7. HENGRUI PHARMA

Jiangsu Hengrui Pharmaceuticals Co Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. Out of these eq 10mg base/ml version comes by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Hengrui Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Aug 30, 2017
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Sep 19, 2017





8. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Apr 19, 2023
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Dec 18, 2023


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





9. HOSPIRA

Hospira Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Mar 30, 2018
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Mar 30, 2018


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Clayton Hospira, Inc.
Lake Forest Hospira Inc
Mcpherson Hospira, Inc., A Pfizer Company
Morgan Hill Hospira Inc
Rocky Mount Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





10. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

(reference standard)

injectable Prescription INJECTION AP Apr 25, 2019
EQ 10MG BASE/ML

(reference standard)

injectable Prescription INJECTION AP Apr 25, 2019





11. PIRAMAL

Piramal Healthcare Uk Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Piramal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Discontinued INJECTION N/A Mar 11, 2022
EQ 10MG BASE/ML

injectable Discontinued INJECTION N/A Mar 11, 2022





12. PIRAMAL CRITICAL

Piramal Critical Care Inc has filed for 1 generic for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Piramal Critical.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Dec 14, 2022


Manufacturing Plant Locations
New

Piramal Critical's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Piramal Critical as present at those locations.

Country City Firm Name
United States
Bethlehem Piramal Critical Care, Inc.





13. SAGENT PHARMS INC

Sagent Pharmaceuticals Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Nov 6, 2020
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Nov 6, 2020





14. SANDOZ INC

Sandoz Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Sandoz Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Feb 3, 2012
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Feb 3, 2012


Manufacturing Plant Locations
New

Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.

Country City Firm Name
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc





15. SOMERSET

Somerset Therapeutics Llc has filed for 1 generic for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Somerset.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Apr 24, 2019


Manufacturing Plant Locations
New

Somerset's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Somerset as present at those locations.

Country City Firm Name
United States
Somerville Somerset Medical Center IRB
Fairfield Somerset Auction Company, LLC
India
Bengaluru Somerset Therapeutics Limited





16. SOMERSET THERAPS LLC

Somerset Therapeutics Llc has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Prescription INJECTION AP Feb 20, 2019
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Feb 20, 2019





17. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE/ML

injectable Discontinued INJECTION N/A Aug 31, 2020
EQ 10MG BASE/ML

injectable Prescription INJECTION AP Nov 4, 2019